BSE · HAMPS
HAMPS BIO LIMITED
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,086
of 5,084 stocks
🏆 New peak
▲ 81W
Peak #4,086 · 30 Sep 2026
HAMPS BIO LIMITED is a microcap company in the Healthcare space and is growing revenue at a solid clip, remains firmly promoter-controlled, with promoters holding 72%, and commands a premium earnings multiple.
Market Cap
20.86 Cr
P/E Ratio
28.16
P/B Ratio
—
ROE
—
ROCE
-3.67%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
Quarterly financials for this stock haven't been ingested yet — check back soon.
Shareholding pattern
Promoter
71.99%
Public
28.01%
PUBLIC BREAKDOWN
Individuals
26.63%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 08 Sep 2025 | Bonus | Bonus issue 1:1 |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.